This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (37)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cardiovascular System  • Prognosis/ Outcomes  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)

Tiny Jaarsma, PhD; Martje H. L. van der Wal, PhD; Ivonne Lesman-Leegte, MSc; Marie-Louise Luttik, PhD; Jochem Hogenhuis, PhD; Nic J. Veeger, MSc; Robbert Sanderman, PhD; Arno W. Hoes, MD; Wiek H. van Gilst, PhD; Dirk J. A. Lok, MD; Peter H. J. M. Dunselman, MD; Jan G. P. Tijssen, PhD; Hans L. Hillege, MD; Dirk J. van Veldhuisen, MD; for the Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) Investigators

Arch Intern Med. 2008;168(3):316-324.

Background:  Heart failure (HF) disease management programs are widely implemented, but data about their effect on outcome have been inconsistent.

Methods  The Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH) was a multicenter, randomized, controlled trial in which 1023 patients were enrolled after hospitalization because of HF. Patients were assigned to 1 of 3 groups: a control group (follow-up by a cardiologist) and 2 intervention groups with additional basic or intensive support by a nurse specializing in management of patients with HF. Patients were studied for 18 months. Primary end points were time to death or rehospitalization because of HF and the number of days lost to death or hospitalization.

Results  Mean patient age was 71 years; 38% were women; and 50% of patients had mild HF and 50% had moderate to severe HF. During the study, 411 patients (40%) were readmitted because of HF or died from any cause: 42% in the control group, and 41% and 38% in the basic and intensive support groups, respectively (hazard ratio, 0.96 and 0.93, respectively; P = .73 and P = .52, respectively). The number of days lost to death or hospitalization was 39 960 in the control group, 33 731 days for the basic intervention group (P  = .81), and 34 268 for the intensive support group (P  = .49). All-cause mortality occurred in 29% of patients in the control group, and there was a trend toward lower mortality in the intervention groups combined (hazard ratio, 0.85; 95% confidence interval, 0.66-1.08; P = .18). There were slightly more hospitalizations in the 2 intervention groups (basic intervention group, P  = .89; and intensive support group, P  = .60).

Conclusions  Neither moderate nor intensive disease management by a nurse specializing in management of patients with HF reduced the combined end points of death and hospitalization because of HF compared with standard follow-up. There was a nonsignificant, potentially relevant reduction in mortality, accompanied by a slight increase in the number of short hospitalizations in both intervention groups.

Clinical Trial Registry  http://trialregister.nl Identifier: NCT 98675639

Author Affiliations: Departments of Cardiology (Drs Jaarsma, van der Wal, Luttik, Hogenhuis, van Gilst, Hillege, and van Veldhuisen, Ms Lesman-Leegte, and Mr Veeger) and Psychology (Dr Sanderman), University Medical Center Groningen, University of Groningen, Groningen; Division Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht (Dr Hoes); Deventer Hospital, Deventer (Dr Lok); Amphia Hospital, Breda (Dr Dunselman); and Academic Medical Center Amsterdam, Amsterdam (Dr Tijssen), the Netherlands.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen et al.
J Am Coll Cardiol 2009;53:2150-2158.
ABSTRACT | FULL TEXT  

Self-rated health and mortality in patients with chronic heart failure
Farkas et al.
Eur J Heart Fail 2009;11:518-524.
ABSTRACT | FULL TEXT  

Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology
Jaarsma et al.
Eur J Heart Fail 2009;11:433-443.
ABSTRACT | FULL TEXT  

Incidence and predictors of hospitalization or death in patients managed in multidisciplinary heart failure clinics
Gustafsson et al.
Eur J Heart Fail 2009;11:413-419.
ABSTRACT | FULL TEXT  

A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study
Dar et al.
Eur J Heart Fail 2009;11:319-325.
ABSTRACT | FULL TEXT  

The European Heart Failure Self-care Behaviour scale revised into a nine-item scale (EHFScB-9): a reliable and valid international instrument
Jaarsma et al.
Eur J Heart Fail 2009;11:99-105.
ABSTRACT | FULL TEXT  

Tele-guidance of chronic heart failure patients enhances knowledge about the disease. A multi-centre, randomised controlled study
Balk et al.
Eur J Heart Fail 2008;10:1136-1142.
ABSTRACT | FULL TEXT  

Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study
Arya et al.
Eur J Heart Fail 2008;10:1143-1148.
ABSTRACT | FULL TEXT  

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Authors/Task Force Members et al.
Eur Heart J 2008;29:2388-2442.
FULL TEXT  

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Dickstein et al.
Eur J Heart Fail 2008;10:933-989.
FULL TEXT  

Secondary prevention of coronary heart disease and heart failure in primary care
Jaarsma
Heart 2008;94:1211-1211.
FULL TEXT  

Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF)
Braunschweig et al.
Eur J Heart Fail 2008;10:907-916.
ABSTRACT | FULL TEXT  

Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452
Coletta et al.
Eur J Heart Fail 2008;10:917-920.
ABSTRACT | FULL TEXT  

The authors' reply:
Khunti et al.
Heart 2008;94:1211-1211.
FULL TEXT  

Psychology and cardiology: do not forget the heart failure patient
Jaarsma et al.
Eur Heart J 2008;29:1208-1208.
FULL TEXT  

Do Disease Management Programs Really Make a Difference in Heart Failure?
Journal Watch Cardiology 2008;2008:3-3.
FULL TEXT  

When, how and where should we "coach" patients with heart failure: The COACH results in perspective
Jaarsma and van Veldhuisen
Eur J Heart Fail 2008;10:331-333.
FULL TEXT